Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer research, microRNA, Biology, Carcinogenesis, Colorectal cancer, and Breast cancer.
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer
Knockout of both miR-15/16 loci induces acute myeloid leukemia
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia
LONG-NONCODING RNAs in gastroesophageal cancers
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
miR-15b/16-2 deletion promotes B-cell malignancies
microRNA classifiers are powerful diagnostic/prognostic tools in <i>ALK-</i> , <i>EGFR-</i> , and <i>KRAS</i> -driven lung cancers
MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression
Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
Next generation analysis of breast cancer genomes for precision medicine
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas
Anti-miR-135b in colon cancer treatment: Results from a preclinical study.
Abstract B14: Anti-miR-135b in colon cancer treatment